Cardiovascular Systems Inc (CSII) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CSII Annual Cash Flow →
Quarterly cash flow trends provide additional context on Cardiovascular Systems Inc's liquidity and ability to support ongoing operations and capital needs.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
6 Months
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Operating Activities
Income-18.52
Depreciation & amortization1.80
Amortization of Other Assets0.69
Increase (Decrease) in Deferred Revenue1.78
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.05
Increase (Decrease) in Inventories-6.62
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation7.99
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Depreciation And Amortization Of Property And Equipment-
Provision for Doubtful Accounts Including Notes Receivable-
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Income taxes-0.07
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.61
Increase (Decrease) in Accounts Payable2.67
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-5.46
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.28
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.62
Discontinued operations0.00
Net Cash flow from Operating Activities-17.20
Investing Activities
Capital Expenditures-2.73
Sale of Capital Items0.00
Short-term Investments Proceeds74.26
Short-term Investments Acq.-61.06
Real Estate Investments0.00
Payments To Acquire Intangible Assets Purchased-1.70
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities10.47
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.50
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.35
Exercise Of Stock Options And Warrants-
Proceeds From Exercise Of Stock Options And Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.15
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-19.93
Total Cash Flow-6.58
4 historic quarters locked

Sign in to unlock the full Cardiovascular Systems Inc cash flow history.

About Cardiovascular Systems Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001180145-23-000016

Figures are derived from filed reports and may be restated. Historical data is subject to revision.